Q3 2022 Holdings
Filed 2022-11-14 | 73 holdings | $324.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $37.6K | 3,163,795 | 0.0% |
| Merus N V | COM | N5749R100 | $38.1K | 1,900,000 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $41.0K | 2,154,058 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $42.8K | 3,571,928 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $42.8K | 1,094,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $48.5K | 2,169,132 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $56.7K | 6,448,359 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $78.6K | 3,984,264 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $89.0K | 1,303,700 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $97.6K | 3,421,541 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $101.1K | 1,714,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $139.7K | 2,000,000 | 0.0% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $351.0K | 540,000 | 0.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $3.4M | 2,014,858 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $6.3M | 425,000 | 2.0% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $6.4M | 500,000 | 2.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $7.2M | 70,000 | 2.2% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $13.8M | 1,074,082 | 4.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $20.7M | 1,263,930 | 6.4% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $37.5M | 1,432,200 | 11.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $58.7M | 2,084,000 | 18.1% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $67.4M | 500,000 | 20.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $101.7M | 2,100,000 | 31.3% |